Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Docetaxel | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C43H53NO14. CAS No. 114977-28-5. Prepack ID : 75180981-100mg. Molecular Weight : 807.88. |  |
| Docetaxel | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C43H53NO14. CAS No. 114977-28-5. Prepack ID : 75180981-1g. Molecular Weight : 807.88. | |
| Docetaxel | 500mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C43H53NO14. CAS No. 114977-28-5. Prepack ID : 75180981-500mg. Molecular Weight : 807.88. | |
| Docetaxel | Docetaxel, also called Taxoltere metro, a semisynthetic side-chain analogue of taxol differing at two positions in its chemical structure, is an inhibitior of microtubule disassembly (IC50 = 0.2 μM). And it inhibits cell replication (IC50 = 0.13 μM). Uses: Antitumor. Group: Pharmaceutical. Alternative Names: docetaxel; docetaxel anhydrous; docetaxel hydrate; docetaxel trihydrate; docetaxol; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol; NSC 628503; RP 56976; RP-56976; Taxoltere metro; 114977-28-5. CAS No. 114977-28-5. Pack Sizes: 5 g. Product ID: NP3347. Molecular formula: C43H53NO14. Mole weight: 807.88. Custom synthesis is available. Send your inquiries for more information. |  London |
| Docetaxel Related Compound 1 ((2R, 3S)-3-Phenylisoserine) | Intermediate for the synthesis of taxol. Group: Pharmaceutical. Alternative Names: (2R,3S)-3-Amino-2-hydroxy-3-phenyl-propanoic acid. CAS No. 136561-53-0. Pack Sizes: 1mg;1g;10g. Product ID: BAT-008064. Molecular formula: C9H11NO3. Mole weight: 181.19. Custom synthesis is available. Send your inquiries for more information. | London |
| 10-Deacetylbaccatin III | 10-Deacetylbaccatin-III is an antineoplastic agent and an anti-cancer intermediate. Group: Pharmaceutical. Alternative Names: 10-Deacetylbaccatin (USP); 10-Deacetylbaccatin III; 10-desacetyl-baccatin III (EP); 5β,20-epoxy-4-(acetyloxy)-1,7β,10β,13α-tetrahydroxy-9-oxotax-11-en-2α-yl benzoate; Docetaxel EP Impurity E. CAS No. 32981-86-5. Pack Sizes: 100 mg. Product ID: NP1767. Molecular formula: C29H36O10. Mole weight: 544.59. Custom synthesis is available. Send your inquiries for more information. | London |
| 16-Dehydropregnenolone acetate | 16-Dehydropregnenolone acetate is an impurity of Abiraterone, which is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Alternative Names: Dehydropregnenolone acetate; 16,17-Didehydropregnenolone acetate. CAS No. 979-02-2. Pack Sizes: 25 g. Product ID: NP6241. Molecular formula: C23H32O3. Mole weight: 356.51. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Deoxy-3-acetyl abiraterone-3-ene | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Alternative Names: 1-((8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl)ethanone. Pack Sizes: 10 mg. Product ID: B0038-007224. Molecular formula: C26H31NO. Mole weight: 373.54. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Deoxy 3-chloroabiraterone | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Alternative Names: 3-((8R,9S,10R,13S,14S)-3-Chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine. Pack Sizes: 10 mg. Product ID: B0038-007226. Molecular formula: C24H30ClN. Mole weight: 367.95. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid | Docetaxel intermediate. Uses: Docetaxel or paclitaxel intermediate. Group: Pharmaceutical. Alternative Names: (4S,5R)-2,2-dimethyl-3-[(2-methylpropan-2-yl)oxy-oxomethyl]-4-phenyl-5-oxazolidinecarboxylic acid; (4S,5R)-2,2-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid. CAS No. 143527-70-2. Pack Sizes: 1mg;1g;10g. Product ID: NP3207. Molecular formula: C17H23NO5. Mole weight: 321.37. Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone isopropyl ether | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Alternative Names: 3-[3-(1-Methylethoxy)androsta-5,16-dien-17-yl]pyridine; 3-((3S,8R,9S,10R,13S,14S)-3-Isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine. CAS No. 2484719-15-3. Pack Sizes: 1mg;1g;10g. Product ID: 2484719-15-3. Molecular formula: C27H37NO. Mole weight: 391.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone Methyl Ether | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Alternative Names: 3-[(3β)-3-Methoxyandrosta-5,16-dien-17-yl]pyridine; 3-((3S,8R,9S,10R,13S,14S)-3-Methoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine. CAS No. 1470276-23-3. Pack Sizes: 1mg;1g;10g. Product ID: 1470276-23-3. Molecular formula: C25H33NO. Mole weight: 363.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Abiraterone O-β-D-glucuronide | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Alternative Names: Abiraterone O-beta-D-glucuronide; (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol β-D-Glucuronide. CAS No. 2307194-33-6. Pack Sizes: 1mg;1g;10g. Product ID: 2307194-33-6. Molecular formula: C30H39NO7. Mole weight: 525.63. Custom synthesis is available. Send your inquiries for more information. | London |
| Anhydro abiraterone | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga. Group: Pharmaceutical. Alternative Names: 3-Androsta-3,5,16-trien-17-yl-pyridine; 3-((8R,9S,10R,13S,14S)-10,13-Dimethyl-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 17-(3-Pyridyl)androsta-3,5,16-triene. CAS No. 154229-20-6. Pack Sizes: 10 mg. Product ID: B0038-007225. Molecular formula: C24H29N. Mole weight: 331.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-3-Phenylisoserine | An intermediate of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Group: Pharmaceutical. Alternative Names: (2R,3S)-Boc-3-Phenylisoserine; Boc-(2R,3S)-3-phenylisoserine; (2R,3S)-N-Boc-3-Phenylisoserine; (2R,3S)-3-(Boc-amino)-2-hydroxy-3-phenyl-propanoic acid. CAS No. 145514-62-1. Pack Sizes: 500 mg. Product ID: BAT-008068. Molecular formula: C14H19NO5. Mole weight: 281.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Cabazitaxel intermediate | Cabazitaxel intermediate is extracted from the barks of Taxus yunnanensis. Group: Pharmaceutical. Alternative Names: 5-[(2α,5β,7β,10β,13α)-4-Acetoxy-2-(benzoyloxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-13-yl] 3-(2-methyl-2-propanyl) (4S,5R)-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate; 3,5-Oxazolidinedicarboxylic acid, 2-(4-methoxyphenyl)-4-phenyl-, 5-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl] 3-(1,1-dimethylethyl) ester, (4S,5R)-; Cabazitaxel N-2; Docetaxel Impurity 62. CAS No. 1354900-65-4. Pack Sizes: 1 mg. Product ID: NP1479. Molecular formula: C51H59NO15. Mole weight: 926.02. Custom synthesis is available. Send your inquiries for more information. | London |
| DUPA(OtBu)-OH | DUPA(OtBu)-OH is a PEG linker for antibody-drug-conjugation (ADC). DUPA(OtBu)-OH is a DUPA precursor. DUPA is used as the targeting moiety to actively deliver Docetaxel (DTX) for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer. Group: Pharmaceutical. Alternative Names: (S)-5-tert-Butoxy-4-(3-((s)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic Acid; L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester; 2-[3-(1,3-bis-tert-butoxycarbonylpropyl)ureido]pentanedioic acid 1-tert-butyl ester. CAS No. 1026987-94-9. Pack Sizes: 500 mg. Product ID: BADC-00511. Molecular formula: C23H40N2O9. Mole weight: 488.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Paclitaxel | Paclitaxel is a compound with anti-tumor activity extracted from the Pacific yew tree Taxus brevifolia. Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells. Uses: Adcs cytotoxin. Group: Pharmaceutical. Alternative Names: Docetaxel EP Impurity F; BMS 181339-01; BMS181339-01; BMS-181339-01; Taxol A; Abraxane; Paxene; Taxol. CAS No. 33069-62-4. Pack Sizes: 2 g. Product ID: BBF-04014. Molecular formula: C47H51NO14. Mole weight: 853.91. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
